Pharmaceutical Executive March 26, 2025
Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, discusses ethical considerations surrounding AI use in medication access and how the industry can ensure that these technologies are used responsibly and equitably.
In this Pharmaceutical Executive video interview, Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, discusses “The 2025 Medication Access Report.” She highlights gaps in data-sharing and cross-functional collaboration as major bottlenecks that cause delays, rework, and increased patient burden. Chiang shares that only 3% of patients utilize support programs due to a lack of awareness. A large majority of the report’s respondents plan to expand funding for patient support programs within the next 5 years due to large number of new therapies expected to come...
Today's Sponsors
Today's Sponsor